Chlorhexidine
Active ingredient · 8 therapeutic classes
Sold as DERMOL 200 SHOWER…
- Drug class
- Antiinfectives
- Availability
- Prescription and OTC
- Routes
- Oral, Topical, Topical (Commercial)
- Markets covered
- 3
- Products on record
- 21
Overview
Plain-language summary, compiled from the cited regulatory records
Chlorhexidine is an anti-infective and antiseptic agent approved for local oral treatment [1]. It is utilized as a healthcare personnel handwash to help reduce bacteria that may cause disease [1].
This active ingredient belongs to the drug class of antiinfectives and antiseptics for local oral treatment, categorized under A01AB [1]. While specific brand examples were not provided in the source data, chlorhexidine is available in various formulations and is marketed under several brand names [1].
The provided data does not contain information on adverse event reports or top reactions associated with chlorhexidine.
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 15 | May 22, 2026 |
| US United States | FDA | 3 | January 12, 2023 |
| CA Canada | Health Canada | 3 | March 22, 2025 |
GBUnited Kingdom· MHRA
15 products
Uses
Eczmol/Cetraben Protect Cream is an antimicrobial emollient which can also be used as an alternative to soap in the management of dry and pruritic skin conditions including eczema and dermatitis.
How to take
USUnited States· FDA
3 products
Uses
Use healthcare personnel handwash: helps reduce bacteria that potentially can cause disease
How to take
CACanada· Health Canada
3 products
3 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Drug interactions
Known interactions involving Chlorhexidine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL068310242 · revised July 12, 2024
- [2]FDA DailyMed · 014a5f36-0396-49… · revised December 26, 2022 [PDF]
- [3]Health Canada (DPD) · 00832146 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.